Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The cystine/glutamate antiporter system x c - in health and disease: From molecular mechanisms to novel therapeutic opportunities
A randomized phase II study of nab-paclitaxel + durvalumab + neoantigen vaccine versus nab-paclitaxel + durvalumab in metastatic triple-negative breast cancer (mTNBC)
These combined bioactivities position BPC-157 as a promising research compound for studies in tissue repair, angiogenesis, and inflammatory modulation
and akirolu, H
These effects extend beyond in vitro experiments
US$ 20.71
US$ 29.67
US$ 25.75
US$ 26.37
US$ 20.26
US$ 20.90
US$ 26.08
US$ 24.17
